Status:
RECRUITING
Development of Isthmocele Symptom Severity and Quality of Life Scale
Lead Sponsor:
Hilal Yuvacı
Conditions:
Quality of Life
Eligibility:
FEMALE
18-45 years
Brief Summary
Isthmocele, also known as cesarean scar defect (CSD), is the disruption of the integrity of the myometrium in the cesarean section incision and the indentation of the opening in the myometrium towards...
Detailed Description
Patients with isthmocele symptoms three months after cesarean delivery will be included in the study.The study will not include findings that may be confused with isthmocele symptoms, such as uterine ...
Eligibility Criteria
Inclusion
- Patients with isthmocele symptoms three months after cesarean delivery will be included in the study.
Exclusion
- The study will not include findings that may be confused with isthmocele symptoms, such as uterine fibroids and endometrial polyps.
- Patients with acute vaginitis and pelvic inflammatory disease will not be included in the study.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT06562231
Start Date
January 1 2023
End Date
December 30 2025
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sakarya University School of Medicine
Sakarya, Turkey (Türkiye)